Healthcare conglomerate Johnson & Johnson kicks off its bankruptcy plan confirmation Tuesday, in its third attempt to resolve ...
Johnson & Johnson announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous, SC, induction therapy in adults with moderately to ...
It has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have added about 8.9% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Johnson & Johnson begins battle over baby powder’s ‘link to cancer’ in $10 billion case - Courts have rejected J&J’s two ...
In a report released today, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price ...
We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
The Illini lost Johnson to a broken wrist, and his absence compromises the team in ways that may be impossible to make up for ...